Literature DB >> 2841128

Nucleotide sequence and expression in Escherichia coli of the gene coding for sphingomyelinase of Bacillus cereus.

A Yamada1, N Tsukagoshi, S Udaka, T Sasaki, S Makino, S Nakamura, C Little, M Tomita, H Ikezawa.   

Abstract

Bacillus cereus secretes phospholipases C, which hydrolyze phosphatidylcholine, sphingomyelin and phosphatidylinositol. A 7.5-kb HindIII fragment of B. cereus DNA cloned into Escherichia coli, with pUC18 as a vector, directed the synthesis of the sphingomyelin-hydrolyzing phospholipase C, sphingomyelinase. Nucleotide sequence analysis of the subfragment revealed that it contained two open reading frames in tandem. The upstream truncated open reading frame corresponds to the carboxy-terminal portion of the phosphatidylcholine-hydrolyzing phospholipase C, and the downstream open reading frame to the entire translational portion of the sphingomyelinase. The two phospholipase C genes form a gene cluster. As inferred from the DNA sequence, the B. cereus sphingomyelinase has a signal peptide of 27 amino acid residues and the mature enzyme comprises 306 amino acid residues, with a molecular mass of 34233 Da. The signal peptide of the enzyme was found to be functional in protein transport across the membrane of E. coli. The enzymatic properties of the sphingomyelinase synthesized in E. coli resemble those of the donor strain sphingomyelinase. The enzymatic activity toward sphingomyelin was enhanced 20-30-fold in the presence of MgCl2, and the adsorption of the enzyme onto erythrocyte membranes was accelerated in the presence of CaCl2.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841128     DOI: 10.1111/j.1432-1033.1988.tb14186.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  26 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 2.  The neutral sphingomyelinase family: identifying biochemical connections.

Authors:  Christopher J Clarke; Bill X Wu; Yusuf A Hannun
Journal:  Adv Enzyme Regul       Date:  2010-10-28

3.  Molecular cloning and expression of Mn(2+)-dependent sphingomyelinase/hemolysin of an aquatic bacterium, Pseudomonas sp. strain TK4.

Authors:  Noriyuki Sueyoshi; Katsuhiro Kita; Nozomu Okino; Keishi Sakaguchi; Takashi Nakamura; Makoto Ito
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

4.  Studies on the active sites ofBacillus cereus sphingomyelinase substitution of some amino acids by site-directed mutagenesis.

Authors:  H Ikezawa; K Tameishi; A Yamada; H Tamura; K Tsukamoto; Y Matsuo; K Nishikawa
Journal:  Amino Acids       Date:  1995-09       Impact factor: 3.520

5.  A distant evolutionary relationship between bacterial sphingomyelinase and mammalian DNase I.

Authors:  Y Matsuo; A Yamada; K Tsukamoto; H Tamura; H Ikezawa; H Nakamura; K Nishikawa
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

6.  Nucleotide sequence: the beta-hemolysin gene of Staphylococcus aureus.

Authors:  S J Projan; J Kornblum; B Kreiswirth; S L Moghazeh; W Eisner; R P Novick
Journal:  Nucleic Acids Res       Date:  1989-04-25       Impact factor: 16.971

Review 7.  Protein secretion in Bacillus species.

Authors:  M Simonen; I Palva
Journal:  Microbiol Rev       Date:  1993-03

8.  Hemolysin II is more characteristic of Bacillus thuringiensis than Bacillus cereus.

Authors:  Z I Budarina; M A Sinev; S G Mayorov; A Y Tomashevski; I V Shmelev; N P Kuzmin
Journal:  Arch Microbiol       Date:  1994       Impact factor: 2.552

9.  Hemolytic and sphingomyelinase activities of Clostridium perfringens alpha-toxin are dependent on a domain homologous to that of an enzyme from the human arachidonic acid pathway.

Authors:  R W Titball; D L Leslie; S Harvey; D Kelly
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

10.  Phosphatidylcholine-specific phospholipase C and sphingomyelinase activities in bacteria of the Bacillus cereus group.

Authors:  A P Pomerantsev; K V Kalnin; M Osorio; S H Leppla
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.